SeaCrest Wealth Management’s Idexx Laboratories IDXX Stock Holding History

SeaCrest Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-330	Closed	-$236K	–	657
2025 Q4	$236K	Sell	330 -10	-3%	-$6.81K	0.02%	534
2025 Q3	$214K	Buy	+340	New	+$206K	0.02%	577
2022 Q3	–	Sell	-370	Closed	-$130K	–	1022
2022 Q2	$130K	Buy	370 +3	+0.8%	+$1.22K	0.02%	758
2022 Q1	$201K	Buy	367 +16	+5%	+$8.42K	0.02%	656
2021 Q4	$231K	Sell	351 -300	-46%	-$188K	0.03%	600
2021 Q3	$405K	Hold	651	–	–	0.05%	402
2021 Q2	$411K	Buy	651 +2	+0.3%	+$1.1K	0.05%	397
2021 Q1	$318K	Buy	649 +83	+15%	+$41.6K	0.04%	443
2020 Q4	$283K	Sell	566 -1	-0.2%	-$447	0.04%	456
2020 Q3	$223K	Buy	+567	New	+$210K	0.04%	482
2019 Q2	–	Sell	-573	Closed	-$128K	–	1119
2019 Q1	$128K	Hold	573	–	–	0.02%	607
2018 Q4	$107K	Buy	573 +4	+0.7%	+$820	0.02%	640
2018 Q3	$142K	Buy	569 +22	+4%	+$5.34K	0.02%	625
2018 Q2	$119K	Buy	547 +33	+6%	+$6.8K	0.02%	668
2018 Q1	$98K	Hold	514	–	–	0.02%	710
2017 Q4	$80K	Buy	+514	New	+$80.9K	0.01%	799

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SeaCrest Wealth Management's IDXX Position: Q1 2026 in Review

SeaCrest Wealth Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 330 shares — an estimated $236K sold.

SeaCrest Wealth Management first reported a position in IDXX in Q4 2017 and held it in 16 quarters. The position peaked at $411K in Q2 2021. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

SeaCrest Wealth Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
SeaCrest Wealth Management sold 330 Idexx Laboratories shares in Q1 2026, an estimated $236K.
SeaCrest Wealth Management first reported a position in Idexx Laboratories in Q4 2017 and held it in 16 quarters.
SeaCrest Wealth Management's Idexx Laboratories position peaked at $411K in Q2 2021.
1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on SeaCrest Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.